GlassScriptPhysician profile
Elina Brick
NPI 1801348701
$518.27
in general payments reported to CMS, 2019-2025
16 companies · $518 in 2025
The $518 reported for 2025 was more than what 77% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $135.57 | 2025 | |
| Boston Scientific Corporation | $40.76 | 2025 | General - Therapies, Wavewriter Alpha Prime 16 |
| Incyte Corporation | $38.84 | 2025 | Niktimvo, Jakafi |
| Astellas Pharma US INC | $36.81 | 2025 | Cresemba |
| Adaptive Biotechnologies Corporation | $35.45 | 2025 | Clonoseq |
| Melinta Therapeutics, LLC | $32.53 | 2025 | Rezzayo |
| Sanofi-Aventis U.S. LLC | $28.67 | 2025 | |
| Celgene Corporation | $25.92 | 2025 | Breyanzi |
| Merck Sharp & Dohme LLC | $21.80 | 2025 | Prevymis |
| Sobi, INC | $18.95 | 2025 | |
| Abbvie INC. | $18.83 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $18.35 | 2025 | Sancuso |
| Janssen Biotech, INC. | $17.02 | 2025 | Darzalex |
| Daiichi Sankyo INC. | $16.52 | 2025 | Vanflyta |
| Adc Therapeutics America, INC. | $16.23 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $16.02 | 2025 | Venclexta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elina Brick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.